Pinnacle Advisory Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-4,940
| Closed | -$377K | – | 170 |
|
|
2019
Q3 | $377K | Sell |
4,940
-13,563
| -73% | -$1.04M | 0.03% | 126 |
|
|
2019
Q2 | $1.62M | Buy |
18,503
+2,120
| +13% | +$186K | 0.11% | 64 |
|
|
2019
Q1 | $1.48M | Buy |
16,383
+670
| +4% | +$60.6K | 0.1% | 64 |
|
|
2018
Q4 | $1.13M | Sell |
15,713
-10,800
| -41% | -$775K | 0.08% | 72 |
|
|
2018
Q3 | $2.54M | Sell |
26,513
-11,271
| -30% | -$1.08M | 0.18% | 41 |
|
|
2018
Q2 | $3.6M | Buy |
37,784
+25,336
| +204% | +$2.41M | 0.22% | 35 |
|
|
2018
Q1 | $1.09M | Buy |
12,448
+4,643
| +59% | +$407K | 0.06% | 77 |
|
|
2017
Q4 | $662K | Buy |
7,805
+415
| +6% | +$35.2K | 0.04% | 113 |
|
|
2017
Q3 | $640K | Buy |
7,390
+620
| +9% | +$53.7K | 0.04% | 105 |
|
|
2017
Q2 | $523K | Buy |
6,770
+815
| +14% | +$63K | 0.03% | 112 |
|
|
2017
Q1 | $413K | Buy |
5,955
+1,870
| +46% | +$130K | 0.03% | 128 |
|
|
2016
Q4 | $242K | Buy |
+4,085
| New | +$242K | 0.02% | 168 |
|